Log In
Saturday 17th March 2018

Back pain drug trial halted

21st July 2010

Arthritis Research UK has said the suspension of a clinical trial involving an experimental drug called tanezumab has been suspended amid safety concerns was further evidence of the need for new, side-effective-free painkillers for chronic back pain and osteoarthritis.

Pharmaceutical company Pfizer said that the trial - along with a separate one involving patients with painful diabetic peripheral neuropathy - has been halted on the request of the US Food and Drug Administration.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018